Utility of polygenic scores for differentiating diabetes diagnosis among patients with atypical phenotypes of diabetes.
Liana K BillingsZhuqing ShiJun WeiAndrew S RifkinS Lilly ZhengBrian T HelfandNadim IlbawiHenry M DunnenbergerPeter J HulickArman QamarJianfeng XuPublished in: The Journal of clinical endocrinology and metabolism (2023)
PGST1D and PGST2D can be used to discriminate classic type 1/type 2 diabetes and have potential clinical utility for differentiating these two types of diseases among patients with atypical diabetes.